FGF21 and metabolic dysfunction-associated steatotic liver disease: Previous studies reported FGF21 to be associated with age (Hanks et al., 2015; Herpich et al., 2021), obesity (Zhang et al., 2008), and in NAFLD with the degree of steatosis (Yilmaz et al., 2010).